Key Takeaways
- ORCL shares have plunged 24% across nine consecutive trading sessions, marking the company’s longest losing streak in over three years.
- The software giant’s stock has tumbled 57% from its September 2025 all-time peak of $345.72.
- Wall Street maintains strong conviction with 84% of analysts assigning Buy ratings and a consensus target of $254.84.
- Mounting concerns over aggressive capital spending and a 3.21 debt-to-equity ratio are pressuring shares.
- Insider activity includes Vice Chairman Jeffrey Henley’s $63.7 million share sale on June 24 through a scheduled trading plan.
Oracle (ORCL) stock began Friday’s session at $140.27, extending a sharp downturn that has alarmed shareholders even as Wall Street analysts maintain exceptionally bullish outlooks.
Shares have declined for nine consecutive trading sessions, shedding 24% during that period. This represents ORCL’s most extended losing streak since late December 2021.
Taking a broader view reveals deeper pain. After reaching a 2026 peak of $248.15 on June 1, Oracle has posted losses on 18 of the last 22 trading days. From its record closing high of $345.72 achieved September 10, 2025, shares have cratered 57%.
The decline appears especially unusual given market conditions. The broader software industry has staged a comeback. The iShares Expanded Tech-Software Sector ETF (IGV) has surged over 10% in just the past five sessions. Oracle is heading the wrong way.
Wall Street Maintains Strong Conviction
Analyst sentiment tells a different story than the stock chart. According to FactSet data, 84% of analysts tracking ORCL maintain Buy ratings — the highest percentage in approximately two decades, excluding a brief spike in May 2011.
The average analyst price target stands at $254.84, suggesting approximately 82% potential upside from Thursday’s closing price.
Mizuho analyst Siti Panigrahi maintains a $320 target and considers Oracle among the firm’s preferred investments, highlighting its comprehensive AI capabilities spanning database, cloud infrastructure, and enterprise applications. KeyBanc analysts, who hold a $300 target alongside an Overweight rating, indicated last month they’re “increasingly comfortable” that operating cost growth will remain controlled.
Piper Sandler established a $225 target with an Overweight stance. Bank of America set its target at $240 with a Buy recommendation. Aggregating 38 analyst opinions yields a Moderate Buy consensus with an average target of $268.27.
Capital Spending and Leverage Create Investor Anxiety
Investor concerns don’t stem from Oracle’s operational results — the company exceeded Q4 expectations, delivering $2.11 earnings per share versus the $1.96 estimate, while revenue reached $19.18 billion, representing 20.6% year-over-year growth.
The issue centers on capital allocation. Oracle is deploying significant resources toward AI infrastructure expansion, and Mizuho’s Panigrahi observed the company will probably require external financing to support that capital expenditure program. He identified “financing challenges” as a material risk factor.
The current debt-to-equity ratio of 3.21 represents a significant concern for market participants.
Oracle has also disclosed AI data center profitability uncertainties in its regulatory documents, intensifying investor skepticism about whether the AI infrastructure investment will deliver returns on a timeframe acceptable to the market.
Vice Chairman Jeffrey Henley disposed of 400,000 ORCL shares on June 24 at an average price of $159.16, generating $63.7 million in proceeds. The transaction occurred under a pre-established Rule 10b5-1 trading arrangement and cut his direct ownership position in half.
Oracle’s 52-week low sits at $134.57. With the current price at $140.27, that support level is within striking distance.
